Clinical Trial 6433

Los Angeles, CA 90045

Study Summary:

We are conducting this study to evaluate the safety, tolerability, and effect on the virological response of a new investigational medication in treatment-naive patients with chronic hepatitis C genotype 1 virus infection.

Qualified Participants Must:

• Be at least 18 years of age
• Be able to demonstrate serological evidence of chronic hepatitis c by an anti-HCV antibody test (current or historical)
• Be able to provide evidence of symptoms of chronic hepatitis C for at least 6 months

Qualified Participants May Receive:

Study medication and examinations at no cost, and reimbursements for your time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.